Page last updated: 2024-09-03

imatinib mesylate and Sarcoma, Endometrial Stromal

imatinib mesylate has been researched along with Sarcoma, Endometrial Stromal in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agorastos, T; Bontis, J; Theodoridis, TD; Venizelos, ID; Zafrakas, M; Zepiridis, L1
BalaƱa, C; Gomez, C; Salvatierra, A; Sastre, JM; Tarrats, A1

Reviews

1 review(s) available for imatinib mesylate and Sarcoma, Endometrial Stromal

ArticleYear
KIT protein expression in uterine sarcomas: an immunohistochemical study and review of the literature.
    European journal of gynaecological oncology, 2008, Volume: 29, Issue:3

    Topics: Benzamides; Endometrial Neoplasms; Female; Humans; Imatinib Mesylate; Immunohistochemistry; Leiomyosarcoma; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrimidines; Sarcoma, Endometrial Stromal

2008

Other Studies

1 other study(ies) available for imatinib mesylate and Sarcoma, Endometrial Stromal

ArticleYear
A case of c-kit positive high-grade stromal endometrial sarcoma responding to Imatinib Mesylate.
    Gynecologic oncology, 2006, Volume: 101, Issue:3

    Topics: Adult; Antineoplastic Agents; Benzamides; Female; Humans; Imatinib Mesylate; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Sarcoma, Endometrial Stromal; Vaginal Neoplasms

2006